Late-breaking clinical evidence presented at #ACC2024 shows fundamental design differences in #TAVR devices can impact valve performance. Explore the evidence. https://bit.ly/3U9gHv9 Risk info: https://bit.ly/4cOdzfp
About us
A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.
- Website
-
http://medtronic.com
External link for Medtronic Cardiac and Vascular
- Industry
- Medical Device
- Company size
- 10,001+ employees
- Headquarters
- Minneapolis , MN
- Founded
- 1949
Updates
-
Medtronic Cardiac and Vascular reposted this
Last chance to register! Join Medtronic Cardiac Surgery on July 23rd for the Tips and Tricks for Off-Pump Surgery webinar with Dr. Lorena Montes. https://bit.ly/469Y8va
-
Supported by data presented at #NYValves2024, the CoreValve/Evolut™ design has a proven legacy of excellent valve performance against both SAVR and other #TAVR platform.
-
Valve performance is critical, regardless of the platform or procedure. The expanded analysis presented at #NYValves2024 further supports the proven legacy of better valve performance for the Evolut™ design against SAVR.
-
We designed the Evolut™ FX+ #TAVR system with access and performance in mind. Learn more: https://bit.ly/3XHJBEN #EvolutFX+ Risk info: https://bit.ly/45GU2dI
-
Shown in the latest #SMARTtrial data presented at #NYValves2024, the clearest predictor of valve performance is valve design. Risk info: https://bit.ly/3zkruuA
-
We designed the Evolut™ FX+ #TAVR system with access and performance in mind. Learn more: https://lnkd.in/g6477crP #EvolutFX+ Risk info: https://lnkd.in/gZrdkYwx
-
Designed with 4x larger windows to enable coronary access while continuing the known performance of the Evolut™ platform. Learn more: https://bit.ly/3VlTHIQ #EvolutFX+ Risk info: https://bit.ly/4etpznr
-
Shown in the latest evidence presented at #EuroPCR, women with a small annuli who are treated with Evolut™ #TAVR receive better valve performance versus SAPIEN platform at one year. https://bit.ly/3VbROys Risk info: https://bit.ly/4bLXne3
-
The Evolut™ FX+ #TAVR system is here! Now with 4x larger windows to enable lifetime management solutions such as coronary access. Learn more: https://bit.ly/3Xal0by #EvolutFX+ Risk info: https://bit.ly/3VbHYwk